Intensity Therapeutics, Inc.
INTS
Positions held
Your positionsINTS isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $12.01M | Enterprise value | $2.58M | Trailing P/E | — | Forward P/E | -1.85 |
| PEG | — | Price / book | 1.18 | Beta | 3.08 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -2.0% | ROA | -89.9% | Debt / equity | 0.01 |
| Current ratio | 5.00 | Free cash flow | -$6.28M | Analyst recommendation | none | Mean target | $19.33 |
| 52w high | $43.50 | 52w low | $3.21 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$3.0M | -$2.4M | -$3.1M | -$2.7M | -$2.5M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$3.1M | -$2.5M | -$3.1M | -$2.7M | -$2.7M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$11.6M | -$16.3M | -$10.5M | -$7.6M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$12.0M | -$16.6M | -$8.3M | -$7.5M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-08 · Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
2026-08-12 · Intensity Therapeutics, Inc. Q2 2026 Earnings Call Summary
2026-08-12 · Intensity Therapeutics (INTS) Q2 2026 Earnings Call Transcript
2026-08-11 · Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
2026-08-04 · Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026
2026-07-15 · Intensity Therapeutics Resumes Dosing in Phase 2 Trial for Investigational Cancer Therapy in Switzerland
Price (daily)
Full chart · RSI · MACD · patterns